Michael Kranda - Director, Ptc Therapeutics, Inc

As of March 18, 2015

Michael Kranda Net Worth

• Net worth is estimated to be at least $314.49K
• Owns at least 2,242 units of Ptc Therapeutics, Inc stock
• Sold an estimated value of $218.83K in the last year at Ptc Therapeutics, Inc

Michael Kranda Trading

• Largest sale of shares was 2,500 units , worth over $182.04K on March 18, 2015
• In total has made about 4 transactions over a year
• Usually trades in March and January, with the busiest year in 2015 and 2014

Michael Kranda Mailing Address

• Mailing address is C/o Vulcan Ventures Incorporated 505 Fifth Avenue, Suite 900 Seattle WA 98104 WA

Ptc Therapeutics, Inc Insider Trading

• The most recent transaction was 897 units sold on April 21, 2022 by Matthew Klein worth over $38.14K
• In the last 9 years, insiders at Ptc Therapeutics, Inc sold an estimated value of $159.5M and bought an estimated value of $101.25M
• The most active traders are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER,  Gregory Neil Almstead, Chief Technical Ops Officer,  and Elliott Mark Boulding, EXEC. VP AND CLO
• Insider trading is most common in January, with the busiest year in 2020